-Medidata, a Dassault Systèmes brand and a leading provider of clinical trial solutions for the life sciences industry announced a new corporate agreement with Bioforum. Bioforum is a biometric CRO serving clinical trial sponsors worldwide.

Building on more than a decade of collaboration, the expanded partnership enables Bioforum's biotech clients to have broader access to Medidata's AI technology, enabling a more agile clinical development experience. Bioforum has conducted 60 studies across a range of therapeutic areas using Medidata solutions such as Medidata Rave EDC and Medidata Rave RTSM, in addition to the addition of Medidata Clinical Data Studio and Medidata eConsent to the CROto streamline data flows, maintain data integrity, and ensure compliance.

Amir Malka, CEO and Co-Founder of Bioforum, said, "With our team of experts, industry-leading biometric services and proprietary technology, Bioforum enables sponsors to seamlessly manage their clinical data in one place and ensure it is secure, accurate and ready for analysis. We are excited to strengthen our alliance with Medidata to provide our clients with the adaptive and advanced solutions they need to thrive."

Janet Butler, Executive Vice President and Global Head of Sales, Medidata, said, "We have expanded our partnership with Bioforum to bring AI-driven clinical trial management to agile biotech startups, accelerating their path to market. By leveraging our patient data monitoring and RBQM platforms, we are providing Bioforum with greater operational efficiency and seamless, high-quality data access for its customers."